title: Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.
authors.forename: Lieke S
authors.initials: LS
authors.lastname: Kamphuis
authors.forename: Wai-Kwan
authors.initials: WK
authors.lastname: Lam-Tse
authors.forename: Willem A
authors.initials: WA
authors.lastname: Dik
authors.forename: Paul L
authors.initials: PL
authors.lastname: van Daele
authors.forename: Paula
authors.initials: P
authors.lastname: van Biezen
authors.forename: Dik J
authors.initials: DJ
authors.lastname: Kwekkeboom
authors.forename: Robert W
authors.initials: RW
authors.lastname: Kuijpers
authors.forename: Herbert
authors.initials: H
authors.lastname: Hooijkaas
authors.forename: Jan A
authors.initials: JA
authors.lastname: van Laar
authors.forename: Jeroen
authors.initials: J
authors.lastname: Bastiaans
authors.forename: G Seerp
authors.initials: GS
authors.lastname: Baarsma
authors.forename: P Martin
authors.initials: PM
authors.lastname: van Hagen
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D017565:Sarcoidosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab